Fort Lauderdale, Florida — Vitality in Aging (VIA) Research Group, a new public benefit research organization, announces its launch with a ground-breaking longitudinal study investigating biomarkers and other measures associated with aging.

The Vitality in Aging Research Group will then launch a formal intervention clinical trial to evaluate the efficacy of specific compounds that have demonstrated regenerative effects in animal models and small proof-of-concept human trials. The in vivo effects of these medical interventions in human study subjects will be measured by individual biomarkers and algorithms of aging.

The VIA Longitudinal Study is modeled after the famous Framingham Heart Study, which produced more scientific discoveries about cardiovascular disease than any other study in history.

The Principal Investigators are James P. Watson, M.D., FCAS, Clinical Faculty member of the David Geffen School of Medicine at the University of California Los Angeles, and Chief Medical Officer of the VIA Research Group, and Brian M. Delaney, President of the Age Reversal Network, and Director of the VIA Research Group.

Aging and its related diseases are the leading causes of death today. The VIA Longitudinal Study and the VIA Interventions Trial together will seek to illuminate the significant risk factors related to declines in functional or biological age as well as to identify potential therapies that may slow or even reverse symptoms associated with aging.

VIA Research Group will begin recruiting study participants and performing various tests during RAADfest, the largest conference on longevity that attracts international speakers and will be held at Westgate Las Vegas Resort & Casino, Las Vegas, Nevada from October 3–6, 2019.

Over the next ten years, VIA Research Group plans to evaluate 1,000 study participants, looking at various biomarkers, as well as lifestyle factors, and physical and cognitive measurements. It is the most comprehensive testing protocol used in an aging study to date, and the study participants will receive access to their results.

For more information or to schedule an interview, contact Tara Smith (561) 203–5761.

###

About Vitality in Aging (VIA) Research Group:

Vitality in Aging (VIA) Research Group logo

Vitality in Aging (VIA) Research Group is located at 3600 West Commercial Boulevard, Fort Lauderdale, Florida. The company’s mission is to break new ground by trying to capture all the factors that influence healthy aging. These factors include but are not limited to, genetic and epigenetic influences on biological age, lifestyle factors and choices such as diet and exercise, pathogens, and of course therapies study participants have undergone in the hopes of slowing the decline in health so many of us experience as we age.

For more information about the VIA Longitudinal Study or Interventions Trial, go to vitalityinaging.org or email info@VitalityInAging.org Connect with us: facebook.com/vitalityinaging; twitter.com/vitalityinaging; instagram.com/vitalityinaging

About RAADfest:

RAADfest is the largest conference on longevity designed for all interest levels. Attendees learn cutting edge information first hand from the scientists, doctors, and visionaries who are pioneering the field of age-reversal. RAADfest includes RAADcity Expo in which the leading longevity brands showcase their products and services and RAADclinic where advanced practitioners offer anti-aging modalities on site. And, with live entertainment, the famous Saturday Night Party and shared meals, RAADfest is a blast as well. Presented by the Coalition for Radical Life Extension, RAADfest is hosted by its dynamic founders, James Strole, and Bernadeane, who are thought leaders on an ageless lifestyle and co-Directors of People Unlimited. For more information go to raadfest.com or to schedule an interview, contact Joe Bardin at 602–361–7567 or email: media@rlecoalition.com.

About Brian M. Delaney:

Brian M. Delaney, Director of the VIA Research Group

Brian M. Delaney is Director of Vitality in Aging Research Group. A doctoral candidate at the University of Chicago, he helped found the Calorie Restriction Society International and has been its president for over twenty years. He has published a book on dietary restriction, with Lisa Walford, The Longevity Diet, as well as numerous articles on dietary restriction and age management medicine in general. He sits on the boards of several age-management medicine-related organizations. He is also President of Age Reversal Network. linkedin.com/in/brian-manning-delaney

About Dr. James P. Watson:

Dr. James P. Watson, Chief Medical Officer of the VIA Research Group

Dr. James P. Watson is the Chief Medical Officer of the VIA Research Group. He is a Board Certified Plastic and Reconstructive Surgeon and a clinical faculty member of the UCLA Division of Plastic & Reconstructive Surgery. He is a Fellow of the American College of Surgeons, a member of the AMA, and also a member of the American Society of Plastic and Reconstructive Surgeons. Currently, he holds a teaching position at Olive View UCLA Medical Center in Sylmar, California, where he teaches the residents in the clinic and in the OR. He is the author and co-editor a surgical textbook and has more than 25 peer-reviewed publications.